|
1
|
Hengpratom T, Kupittayanant S, Churproong
S and Eumkeb G: Lipid-lowering effect of Oroxylum indicum (L.) Kurz
extract in hyperlipidemic mice. Asian Pac J Trop Biomed.
12:148–155. 2022. View Article : Google Scholar
|
|
2
|
Masood B and Moorthy M: Causes of obesity:
A review. Clin Med (Lond). 23:284–291. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Henderson DC, Cagliero E, Gray C,
Nasrallah RA, Hayden DL, Schoenfeld DA and Goff DC: Clozapine,
diabetes mellitus, weight gain, and lipid abnormalities: A
five-year naturalistic study. Am J Psychiatry. 157:975–981. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aggarwal S and Pandey K: Early
identification of PCOS with commonly known diseases: Obesity,
diabetes, high blood pressure and heart disease using machine
learning techniques. Expert Syst Appl. 217:1195322023. View Article : Google Scholar
|
|
5
|
Jin X, Qiu T, Li L, Yu R, Chen X, Li C,
Proud CG and Jiang T: Pathophysiology of obesity and its associated
diseases. Acta Pharm Sin B. 13:2403–2424. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fabbrini E and Magkos F: Obesity and the
pathogenesis of nonalcoholic fatty liver disease. In: Treatment of
the Obese Patient. Springer; Heidelberg: pp. 121–135. 2014
|
|
7
|
Quek J, Chan KE, Wong ZY, Tan C, Tan B,
Lim WH, Tan DJH, Tang ASP, Tay P, Xiao J, et al: Global prevalence
of non-alcoholic fatty liver disease and non-alcoholic
steatohepatitis in the overweight and obese population: A
systematic review and meta-analysis. Lancet Gastroenterol Hepatol.
8:20–30. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Parra-Landazury NM, Cordova-Gallardo J and
Méndez-Sánchez N: Obesity and gallstones. Visc Med. 37:394–402.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mohajan D and Mohajan HK: Obesity and its
related diseases: A new escalating alarming in global health. J
Innov Med Res. 2:12–23. 2023. View Article : Google Scholar
|
|
10
|
Organization WH Obesity, . Preventing and
managing the global epidemic Report of a WHO Consultation.
2000.
|
|
11
|
American Diabetes Association: Diagnosis
and classification of diabetes mellitus. Diabetes Care. 37 (Suppl
1):S81–S90. 2014. View Article : Google Scholar
|
|
12
|
Tarantino G, Finelli C, Scopacasa F,
Pasanisi F, Contaldo F, Capone D and Savastano S: Circulating
levels of sirtuin 4, a potential marker of oxidative metabolism,
related to coronary artery disease in obese patients suffering from
NAFLD, with normal or slightly increased liver enzymes. Oxid Med
Cell Longev. 2014:9206762014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dandona P, Dhindsa S, Chaudhuri A, Bhatia
V, Topiwala S and Mohanty P: Hypogonadotrophic hypogonadism in type
2 diabetes, obesity and the metabolic syndrome. Curr Mol Med.
8:816–828. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li X, Liu Q, Pan Y, Chen S, Zhao Y and Hu
Y: New insights into the role of dietary triglyceride absorption in
obesity and metabolic diseases. Front Pharmacol. 14:10978352023.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Alcantara JMA, Sanchez-Delgado G,
Jurado-Fasoli L, Galgani JE, Labayen I and Ruiz JR: Reproducibility
of the energy metabolism response to an oral glucose tolerance
test: Influence of a postcalorimetric correction procedure. Eur J
Nutr. 62:351–361. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Powell EE, Wong VW and Rinella M:
Non-alcoholic fatty liver disease. Lancet. 397:2212–2224. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mitra S, De A and Chowdhury A:
Epidemiology of non-alcoholic and alcoholic fatty liver diseases.
Transl Gastroenterol Hepatol. 5:162020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Targher G, Tilg H and Byrne CD:
Non-alcoholic fatty liver disease: A multisystem disease requiring
a multidisciplinary and holistic approach. Lancet Gastroenterol
Hepatol. 6:578–588. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Francque SM, Marchesini G, Kautz A,
Walmsley M, Dorner R, Lazarus JV, Zelber-Sagi S, Hallsworth K,
Busetto L, Frühbeck G, et al: Non-alcoholic fatty liver disease: A
patient guideline. JHEP Rep. 3:1003222021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stefan N and Cusi K: A global view of the
interplay between non-alcoholic fatty liver disease and diabetes.
Lancet Diabetes Endocrinol. 10:284–296. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bandyopadhyay S, Samajdar SS and Das S:
Effects of saroglitazar in the treatment of non-alcoholic fatty
liver disease or non-alcoholic steatohepatitis: A systematic review
and meta-analysis. Clin Res Hepatol Gastroenterol. 47:1021742023.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Trevisani F, Frigerio M, Santi V,
Grignaschi A and Bernardi M: Hepatocellular carcinoma in
non-cirrhotic liver: A reappraisal. Dig Liver Dis. 42:341–347.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Day CP and James OF: Steatohepatitis: A
tale of two ‘hits’? Gastroenterology. 114:842–845. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Peiseler M, Schwabe R, Hampe J, Kubes P,
Heikenwälder M and Tacke F: Immune mechanisms linking metabolic
injury to inflammation and fibrosis in fatty liver disease-novel
insights into cellular communication circuits. J Hepatol.
77:1136–1160. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen Z, Tian R, She Z, Cai J and Li H:
Role of oxidative stress in the pathogenesis of nonalcoholic fatty
liver disease. Free Radic Biol Med. 152:116–141. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Y, Xu H, Liu X, Wei W, Jin Q and Wang
X: The structure of triglycerides impacts the digestibility and
bioaccessibility of nutritional lipids during in vitro simulated
digestion. Food Chem. 418:1359472023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Watanabe S and Tsujino S: Applications of
medium-chain triglycerides in foods. Front Nutr. 9:8028052022.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nosaka N, Tsujino S, Honda K, Suemitsu H,
Kato K and Kondo K: Effect of ingestion of medium-chain
triglycerides on substrate oxidation during aerobic exercise could
depend on sex difference in middle-aged sedentary persons.
Nutrients. 13:362020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Abbeddou S, Jimenez EY, Hess SY, Somé JW,
Ouédraogo JB and Brown KH: Small-quantity lipid-based nutrient
supplements, with or without added zinc, do not cause excessive fat
deposition in Burkinabe children: Results from a cluster-randomized
community trial. Eur J Nutr. 61:4107–4120. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lehner F, Demmelmair H, Röschinger W,
Decsi T, Szász M, Adamovich K, Arnecke R and Koletzko B: Metabolic
effects of intravenous LCT or MCT/LCT lipid emulsions in preterm
infants. J Lipid Res. 47:404–411. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Delafosse B, Viale JP, Pachiaudi C,
Normand S, Goudable J, Bouffard Y, Annat G and Bertrand O: Long-and
medium-chain triglycerides during parenteral nutrition in
critically ill patients. Am J Physiol. 272:E550–E555.
1997.PubMed/NCBI
|
|
32
|
Sengupta A and Ghosh M: Hypolipidemic
effect of mustard oil enriched with medium chain fatty acid and
polyunsaturated fatty acid. Nutrition. 27:1183–1193. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shinohara H, Ogawa A, Kasai M and Aoyama
T: Effect of randomly interesterified triacylglycerols containing
medium-and long-chain fatty acids on energy expenditure and hepatic
fatty acid metabolism in rats. Biosci Biotechnol Biochem.
69:1811–1818. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Han J, Hamilton JA, Kirkland JL, Corkey BE
and Guo W: Medium-chain oil reduces fat mass and down-regulates
expression of adipogenic genes in rats. Obes Res. 11:734–744. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wein S, Wolffram S, Schrezenmeir J,
Gasperiková D, Klimes I and Seböková E: Medium-chain fatty acids
ameliorate insulin resistance caused by high-fat diets in rats.
Diabetes Metab Res Rev. 25:185–194. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bourque C, St-Onge MP, Papamandjaris AA,
Cohn JS and Jones PJ: Consumption of an oil composed of medium
chain triacyglycerols, phytosterols, and N-3 fatty acids improves
cardiovascular risk profile in overweight women. Metabolism.
52:771–777. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang LX, Li CX, Kakar MU, Khan MS, Wu PF,
Amir RM, Dai DF, Naveed M, Li QY, Saeed M, et al: Resveratrol (RV):
A pharmacological review and call for further research. Biomed
Pharmacother. 143:1121642021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
St-Onge MP and Bosarge A: Weight-loss diet
that includes consumption of medium-chain triacylglycerol oil leads
to a greater rate of weight and fat mass loss than does olive oil.
Am J Clin Nutr. 87:621–626. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wollin SD, Wang Y, Kubow S and Jones PJ:
Effects of a medium chain triglyceride oil mixture and alpha-lipoic
acid diet on body composition, antioxidant status, and plasma lipid
levels in the Golden Syrian hamster. J Nutr Biochem. 15:402–410.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hill JO, Peters JC, Swift LL, Yang D,
Sharp T, Abumrad N and Greene HL: Changes in blood lipids during
six days of overfeeding with medium or long chain triglycerides. J
Lipid Res. 31:407–416. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ruiz-Sanz J, Aldamiz-Echevarria L,
Arrizabalaga J, Aquino L, Jimeno P, Pérez-Nanclares G and Sanjurjo
P: Polyunsaturated fatty acid deficiency during dietary treatment
of very long-chain acyl-CoA dehydrogenase deficiency. Rescue with
soybean oil. J Inherit Metab Dis. 24:493–503. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Staab CA, Hellgren M, Grafström RC and
Höög JO: Medium-chain fatty acids and glutathione derivatives as
inhibitors of S-nitrosoglutathione reduction mediated by alcohol
dehydrogenase 3. Chem Biol Interact. 180:113–118. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Matulka RA, Thompson DV and Burdock GA:
Lack of toxicity by medium chain triglycerides (MCT) in canines
during a 90-day feeding study. Food Chem Toxicol. 47:35–39. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kaunitz H, Slanetz CA, Johnson RE, Babayan
VK and Barsky G: Nutritional properties of the triglycerides of
saturated fatty acids of medium chain-length. J Am Oil Chem Soc.
35:10–13. 1958. View Article : Google Scholar
|
|
45
|
Kaunitz H, Slanetz CA, Johnson RE and
Babayan VK: Interrelations of linoleic acid with medium-chain and
long-chain saturated triglycerides. J Am Oil Chem Soc. 36:322–325.
1959. View Article : Google Scholar
|
|
46
|
Bionaz M, Thering BJ and Loor JJ: Fine
metabolic regulation in ruminants via nutrient-gene interactions:
Saturated long-chain fatty acids increase expression of genes
involved in lipid metabolism and immune response partly through
PPAR-α activation. Br J Nutr. 107:179–191. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang B, Li L, Fu J, Yu P, Gong D, Zeng C
and Zeng Z: Effects of long-chain and medium-chain fatty acids on
apoptosis and oxidative stress in human liver cells with steatosis.
J Food Sci. 81:H794–H800. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Geng S, Zhu W, Xie C, Li X, Wu J, Liang Z,
Xie W, Zhu J, Huang C, Zhu M, et al: Medium-chain triglyceride
ameliorates insulin resistance and inflammation in high fat
diet-induced obese mice. Eur J Nutr. 55:931–940. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Qin H: Influence of lipofundin vs
intralipid on surgical patients with liver diseases. Chin J Clin
Nutr. 7:129–132. 1999.(In Chinese).
|
|
50
|
Li Z, Zhang L and Wang W: Olive
oil-containing fat emulsion in postoperative parenteral nutrition
of patients with esophageal cancer. Chin J Clin Nutr. 19:2011.(In
Chinese).
|
|
51
|
Zhu M, Wei J, Cao J, Zhao X, Tang D and
Surg YCJCJG: Comparison of nutrition treatment between MCT and LCT
in postoperative elderly patients with gastrointestinal tumor. Chin
J Gastrointest Surg. 5:180–182. 2002.
|
|
52
|
Wang PX, Ji YX, Zhang XJ, Zhao LP, Yan ZZ,
Zhang P, Shen LJ, Yang X, Fang J, Tian S, et al: Targeting CASP8
and FADD-like apoptosis regulator ameliorates nonalcoholic
steatohepatitis in mice and nonhuman primates. Nat Med. 23:439–449.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen L, Li D, Zhan Z, Quan J, Peng J,
Huang Z and Yi B: Sirtuin 2 exacerbates renal tubule injury and
inflammation in diabetic mice via deacetylation of c-Jun/c-Fos.
Cell Mol Life Sci. 82:452025. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Xiao J, Moon M, Yan L, Nian M, Zhang Y,
Liu C, Lu J, Guan H, Chen M, Jiang D, et al: Cellular
FLICE-inhibitory protein protects against cardiac remodelling after
myocardial infarction. Basic Res Cardiol. 107:2392012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cha SI, Groshong SD, Frankel SK, Edelman
BL, Cosgrove GP, Terry-Powers JL, Remigio LK, Curran-Everett D,
Brown KK, Cool CD and Riches DW: Compartmentalized expression of
c-FLIP in lung tissues of patients with idiopathic pulmonary
fibrosis. Am J Respir Cell Mol Biol. 42:140–148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kim MS, Yoon CY, Jang PG, Park YJ, Shin
CS, Park HS, Ryu JW, Pak YK, Park JY, Lee KU, et al: The mitogenic
and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol
Endocrinol. 18:2291–2301. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Singh R, Wang Y, Xiang Y, Tanaka KE,
Gaarde WA and Czaja MJ: Differential effects of JNK1 and JNK2
inhibition on murine steatohepatitis and insulin resistance.
Hepatology. 49:87–96. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhang R, Al-Lamki R, Bai L, Streb JW,
Miano JM, Bradley J and Min W: Thioredoxin-2 inhibits
mitochondria-located ASK1-mediated apoptosis in a JNK-independent
manner. Circ Res. 94:1483–1491. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Han A: Hepatic steatosis assessment:
Harnessing the power of integrating multiple quantitative US
parameters. Radiology. 39:e2324752023. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kouroumalis E, Tsomidis I and Voumvouraki
A: Iron as a therapeutic target in chronic liver disease. World J
Gastroenterol. 29:616–655. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Chardigny JM, Hasselwander O, Genty M,
Kraemer K, Ptock A and Sébédio JL: Effect of conjugated FA on feed
intake, body composition, and liver FA in mice. Lipids. 38:895–902.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Wei Y, Wang D, Topczewski F and
Pagliassotti MJ: Saturated fatty acids induce endoplasmic reticulum
stress and apoptosis independently of ceramide in liver cells. Am J
Physiol Endocrinol Metab. 291:E275–E281. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Cai N, Zhao X, Jing Y, Sun K, Jiao S, Chen
X, Yang H, Zhou Y and Wei L: Autophagy protects against
palmitate-induced apoptosis in hepatocytes. Cell Biosci. 4:282014.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Ohue-Kitano R, Nonaka H, Nishida A,
Masujima Y, Takahashi D, Ikeda T, Uwamizu A, Tanaka M, Kohjima M,
Igarashi M, et al: Medium-chain fatty acids suppress
lipotoxicity-induced hepatic fibrosis via the immunomodulating
receptor GPR84. JCI Insight. 8:e1654692023. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Zeng X, Zhu M, Liu X, Chen X, Yuan Y, Li
L, Liu J, Lu Y, Cheng J and Chen Y: Oleic acid ameliorates palmitic
acid induced hepatocellular lipotoxicity by inhibition of ER stress
and pyroptosis. Nutr Metab (Lond). 17:112020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Roopashree PG, Shetty SS and Kumari NS:
Effect of medium chain fatty acid in human health and disease. J
Funct Foods. 87:1047242021. View Article : Google Scholar
|
|
67
|
Lin KT, Xue JY, Nomen M, Spur B and Wong
PY: Peroxynitrite-induced apoptosis in HL-60 cells. J Biol Chem.
270:16487–16490. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Bauer G: Increasing the endogenous NO
level causes catalase inactivation and reactivation of
intercellular apoptosis signaling specifically in tumor cells.
Redox Biol. 6:353–371. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Pereira S, Park E, Mori Y, Haber CA, Han
P, Uchida T, Stavar L, Oprescu AI, Koulajian K, Ivovic A, et al:
FFA-induced hepatic insulin resistance in vivo is mediated by PKCδ,
NADPH oxidase, and oxidative stress. Am J Physiol Endocrinol Metab.
307:E34–E46. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Subramaiyam N: Insights of mitochondrial
involvement in alcoholic fatty liver disease. J Cell Physiol.
238:2175–2190. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Murayama K, Fukui T, Kushibiki S, Sakamoto
K, Inouchi K and Sugino T: Effects of medium-chain fatty acids and
tributyrin supplementation in milk replacers on growth performance,
blood metabolites, and hormone concentrations in Holstein dairy
calves. J Dairy Sci. 106:4599–4607. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Listenberger LL, Ory DS and Schaffer JE:
Palmitate-induced apoptosis can occur through a
ceramide-independent pathway. J Biol Chem. 276:14890–14895. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Shimabukuro M, Zhou YT, Levi M and Unger
RH: Fatty acid-induced beta cell apoptosis: A link between obesity
and diabetes. Proc Natl Acad Sci USA. 95:2498–2502. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Taheripak G, Bakhtiyari S, Rajabibazl M
and Pasalar P: Meshkani RJFRB and Medicine: Protein tyrosine
phosphatase 1B inhibition ameliorates palmitate-induced
mitochondrial dysfunction and apoptosis in skeletal muscle cells.
Free Radic Biol Med. 65:1435–1446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Sparagna GC, Hickson-Bick DL, Buja LM and
McMillin JB: Fatty acid-induced apoptosis in neonatal
cardiomyocytes: Redox signaling. Antioxid Redox Signal. 3:71–79.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Wang D, Wei Y and Pagliassotti MJ:
Saturated fatty acids promote endoplasmic reticulum stress and
liver injury in rats with hepatic steatosis. Endocrinology.
147:943–951. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Malhi H, Bronk SF, Werneburg NW and Gores
GJ: Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis.
J Biol Chem. 281:12093–12101. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Sokol RJ, Devereaux M, Khandwala R and
O'Brien K: Evidence for involvement of oxygen free radicals in bile
acid toxicity to isolated rat hepatocytes. Hepatology. 17:869–881.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Ozer MK, Parlakpinar H, Cigremis Y, Ucar
M, Vardi N and Acet A: Ischemia-reperfusion leads to depletion of
glutathione content and augmentation of malondialdehyde production
in the rat heart from overproduction of oxidants: Can caffeic acid
phenethyl ester (CAPE) protect the heart? Mol Cell Biochem.
273:169–175. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Rabilloud T, Heller M, Gasnier F, Luche S,
Rey C, Aebersold R, Benahmed M, Louisot P and Lunardi J: Proteomics
analysis of cellular response to oxidative stress: Evidence for in
vivo overoxidation of peroxiredoxins at their active site. J Biol
Chem. 277:19396–19401. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Day CP and James OF: Hepatic steatosis:
Innocent bystander or guilty party? Hepatology. 27:1463–1466. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Cazanave SC, Mott JL, Elmi NA, Bronk SF,
Masuoka HC, Charlton MR and Gores GJ: A role for miR-296 in the
regulation of lipoapoptosis by targeting PUMA. J Lipid Res.
52:1517–1525. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Hoffmann L, Seibt A, Herebian D and
Spiekerkoetter U: Monounsaturated 14: 1n-9 and 16: 1n-9 fatty acids
but not 18: 1n-9 induce apoptosis and necrosis in murine HL-1
cardiomyocytes. Lipids. 49:25–37. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Fauser JK, Matthews GM, Cummins AG and
Howarth GS: Induction of apoptosis by the medium-chain length fatty
acid lauric acid in colon cancer cells due to induction of
oxidative stress. Chemotherapy. 59:214–224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
He X, Wang J, Sun L, Ma W, Li M, Yu S,
Zhou Q and Jiang J: Wogonin attenuates inflammation and oxidative
stress in lipopolysaccharide-induced mastitis by inhibiting
Akt/NF-κB pathway and activating the Nrf2/HO-1 signaling. Cell
Stress Chaperones. 28:989–999. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Xiong Y, Wang J, Wang S, Li H and Zhou X:
Tryptanthrin ameliorates imiquimod-induced psoriasis in mice by
suppressing inflammation and oxidative stress via NF-κB/MAPK/Nrf2
pathways. J Nat Med. 77:188–201. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Halliwell B: Antioxidants in human health
and disease. Annu Rev Nutr. 16:33–50. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Shrake A, Finlayson JS and Ross PD:
Thermal stability of human albumin measured by differential
scanning calorimetry I. Effects of caprylate and
N-acetyltryptophanate. Vox Sang. 47:7–18. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Amir Aslani B and Ghobadi S: Studies on
oxidants and antioxidants with a brief glance at their relevance to
the immune system. Life Sci. 146:163–173. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Olefsky JM and Glass CK: Macrophages,
inflammation, and insulin resistance. Annu Rev Physiol. 72:219–246.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Tomita K, Tamiya G, Ando S, Ohsumi K,
Chiyo T, Mizutani A, Kitamura N, Toda K, Kaneko T, Horie Y, et al:
Tumour necrosis factor α signalling through activation of Kupffer
cells plays an essential role in liver fibrosis of non-alcoholic
steatohepatitis in mice. Gut. 55:415–424. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Shu G, Dai C, Yusuf A, Sun H and Deng X:
Limonin relieves TGF-β-induced hepatocyte EMT and hepatic stellate
cell activation in vitro and CCl4-induced liver fibrosis in mice
via upregulating Smad7 and subsequent suppression of TGF-β/Smad
cascade. J Nutr Biochem. 107:1090392022. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Carrieri P, Mourad A, Marcellin F,
Trylesinski A, Calleja JL, Protopopescu C and Lazarus JV: Knowledge
of liver fibrosis stage among adults with NAFLD/NASH improves
adherence to lifestyle changes. Liver Int. 42:984–994. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Guo HY, Liu B, Yang JW, Jiang SG and Zhang
DC: Characterization, functional analysis and antibacterial
activities of theromacin from the Akoya pearl oyster Pinctada
fucata. Isr J Aquac. Bamidgeh. Dec 25–2021.(Epub ahead of print).
View Article : Google Scholar
|
|
95
|
Ajuwon KM and Spurlock ME: Palmitate
activates the NF-kappaB transcription factor and induces IL-6 and
TNFα expression in 3T3-L1 adipocytes. J Nutr. 135:1841–1846. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Xia J, Wang Z, Yu P, Yan X, Zhao J, Zhang
G, Gong D and Zeng Z: Effect of different medium-chain
triglycerides on glucose metabolism in high-fat-diet induced obese
rats. Foods. 13:2412024. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Puengel T, De Vos S, Hundertmark J,
Kohlhepp M, Guldiken N, Pujuguet P, Auberval M, Marsais F, Shoji
KF, Saniere L, et al: The medium-chain fatty acid receptor GPR84
mediates myeloid cell infiltration promoting steatohepatitis and
fibrosis. J Clin Med. 9:11402020. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
de Castro UG, dos Santos RA, Silva ME, de
Lima WG, Campagnole-Santos MJ and Alzamora AC: Age-dependent effect
of high-fructose and high-fat diets on lipid metabolism and lipid
accumulation in liver and kidney of rats. Lipids Health Dis.
12:1362013. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Silva V, Faria HOF, Sousa-Filho CPB, de
Alvarenga JFR, Fiamoncini J and Otton R: Thermoneutrality or
standard temperature: Is there an ideal housing temperature to
study the antisteatotic effects of green tea in obese mice? J Nutr
Biochem. 120:1094112023. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Hou Y, Zhang Z, Cui Y, Peng C, Fan Y, Tan
C, Wang Q, Liu Z and Gong J: Pu-erh tea and theabrownin ameliorate
metabolic syndrome in mice via potential microbiota-gut-liver-brain
interactions. Food Res Int. 162:1121762022. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Zhang X, Zhao L, Christopher CN, Tabung
FK, Bao W, Garcia DO, Shadyab AH, Saquib N, Neuhouser ML, Tinker LF
and Zhang X: Association of dietary insulinemic and inflammatory
potential with risk of liver cancer and chronic liver disease
mortality in postmenopausal women: A prospective cohort study. Am J
Clin Nutr. 118:530–537. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Throsby KJ: The war on obesity as a moral
project: Weight loss drugs, obesity surgery and negotiating
failure. Science as Culture. 18:201–216. 2009. View Article : Google Scholar
|
|
103
|
Marchesini G, Moscatiello S, Di Domizio S
and Forlani G: Obesity-associated liver disease. J Clin Endocrinol
Metab. 93 (Suppl 1):S74–S80. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Kelner K and Helmuth LJS: Obesity-what is
to be done? American Association for the Advancement of Science.
Science. 845. 2003. View Article : Google Scholar
|
|
105
|
Gura T: Obesity drug pipeline not so fat.
Science. 299:849–852. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Papamandjaris AA, MacDougall DE and Jones
PJ: Medium chain fatty acid metabolism and energy expenditure:
Obesity treatment implications. Life Sci. 62:1203–1215. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Babayan VK: Medium chain triglycerides and
structured lipids. Lipids. 22:417–420. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Sato K, Cho Y, Tachibana S, Chiba T,
Schneider WJ and Akiba Y: Impairment of VLDL secretion by
medium-chain fatty acids in chicken primary hepatocytes is affected
by the chain length. J Nutr. 135:1636–1641. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Shinohara H, Wu J, Kasai M and Aoyama T:
Randomly interesterified triacylglycerol containing medium-and
long-chain fatty acids stimulates fatty acid metabolism in white
adipose tissue of rats. Biosci Biotechnol Biochem. 70:2919–2926.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Zhao B, Luo C, Zhang M, Xing F, Luo S, Fu
S and Sun X: Knockdown of phosphatase and tensin homolog (PTEN)
inhibits fatty acid oxidation and reduces very low density
lipoprotein assembly and secretion in calf hepatocytes. J Dairy
Sci. 103:10728–10741. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Xue C, Liu Y, Wang J, Zhang R, Zhang Y,
Zhang J, Zhang Y, Zheng Z, Yu X, Jing H, et al: Consumption of
medium-and long-chain triacylglycerols decreases body fat and blood
triglyceride in Chinese hypertriglyceridemic subjects. Eur J Clin
Nutr. 63:879–886. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Matsuo T and Takeuchi H: Effects of
structured medium-and long-chain triacylglycerols in diets with
various levels of fat on body fat accumulation in rats. Br J Nutr.
91:219–225. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Ferreira L, Lisenko K, Barros B,
Zangeronimo M, Pereira L and Sousa R: Influence of medium-chain
triglycerides on consumption and weight gain in rats: A systematic
review. J Anim Physiol Anim Nutr (Berl). 98:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
McKenzie KM, Lee CM, Mijatovic J, Haghighi
MM and Skilton MR: Medium-chain triglyceride oil and blood lipids:
A systematic review and meta-analysis of randomized trials. J Nutr.
151:2949–2956. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Lee YY, Tang TK, Chan ES, Phuah ET, Lai
OM, Tan CP, Wang Y, Ab Karim NA, Mat Dian NH and Tan JS: Medium
chain triglyceride and medium-and long chain triglyceride:
metabolism, production, health impacts and its applications-a
review. Crit Rev Food Sci Nutr. 62:4169–4185. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Du YX, Chen SN, Zhu HL, Niu X, Li J, Fan
YW and Deng ZY: Consumption of interesterified medium-and
long-chain triacylglycerols improves lipid metabolism and reduces
inflammation in high-fat diet-induced obese rats. J Agric Food
Chem. 68:8255–8262. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Deng QG, She H, Cheng JH, French SW, Koop
DR, Xiong S and Tsukamoto H: Steatohepatitis induced by
intragastric overfeeding in mice. Hepatology. 42:905–914. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Liu YH, Zhang Y, Xu Q, Yu XM, Zhang XS,
Wang J, Xue C, Yang XY, Zhang RX and Xue CY: Increased
norepinephrine by medium-chain triglyceride attributable to
lipolysis in white and brown adipose tissue of C57BL/6J mice.
Biosci Biotechnol Biochem. 76:1213–1218. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Haemmerle G, Zimmermann R and Zechner R:
Letting lipids go: Hormone-sensitive lipase. Curr Opin Lipidol.
14:289–297. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Liu Y, Xue C, Zhang Y, Xu Q, Yu X, Zhang
X, Wang J, Zhang R, Gong X and Guo C: Triglyceride with
medium-chain fatty acids increases the activity and expression of
hormone-sensitive lipase in white adipose tissue of C57BL/6J mice.
Biosci Biotechnol Biochem. 75:1939–1944. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Clouston AD, Jonsson JR and Powell EE:
Steatosis as a cofactor in other liver diseases: Hepatitis C virus,
alcohol, hemochromatosis, and others. Clin Liver Dis. 11:173–189.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Powell EE, Jonsson JR and Clouston AD:
Steatosis: Co-factor in other liver diseases. Hepatology. 42:5–13.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Li Q, Zhong W, Qiu Y, Kang X, Sun X, Tan
X, Zhao Y, Sun X, Jia W and Zhou Z: Preservation of hepatocyte
nuclear factor-4α contributes to the beneficial effect of dietary
medium chain triglyceride on alcohol-induced hepatic lipid
dyshomeostasis in rats. Alcohol Clin Exp Res. 37:587–598. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Zhao X: Effect of high fat and high sugar
diet on mouse liver redox status. In: Proceedings of the 7th
International Conference on Bioinformatics Research and
Applications. 6–9. 2020.
|
|
125
|
Gerrard SD, Yonke JA, McMillan RP, Sunny
NE and El-Kadi SW: Medium-chain fatty acid feeding reduces
oxidation and causes panacinar steatosis in livers of neonatal
pigs. J Nutr. 154:908–920. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Dauksiene A, Ruzauskas M, Gruzauskas R,
Zavistanaviciute P, Starkute V, Lele V, Klupsaite D,
Klementaviciute J and Bartkiene E: A comparison study of the caecum
microbial profiles, productivity and production quality of broiler
chickens fed supplements based on medium chain fatty and organic
acids. Animals (Basel). 11:6102021. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Lehr L, Canola K, Léger B and Giacobino
JP: Differentiation and characterization in primary culture of
white adipose tissue brown adipocyte-like cells. Int J Obes (Lond).
33:680–686. 2009. View Article : Google Scholar : PubMed/NCBI
|
